Charles B. Schaffer

737 total citations
24 papers, 483 citations indexed

About

Charles B. Schaffer is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Charles B. Schaffer has authored 24 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 5 papers in Pharmacology and 5 papers in Clinical Psychology. Recurrent topics in Charles B. Schaffer's work include Bipolar Disorder and Treatment (11 papers), Schizophrenia research and treatment (6 papers) and Epilepsy research and treatment (4 papers). Charles B. Schaffer is often cited by papers focused on Bipolar Disorder and Treatment (11 papers), Schizophrenia research and treatment (6 papers) and Epilepsy research and treatment (4 papers). Charles B. Schaffer collaborates with scholars based in United States and Japan. Charles B. Schaffer's co-authors include Stephen I. Abramowitz, Michael J. Garvey, Javaid I. Javaid, John M. Davis, Maurice W. Dysken, V.B. Tuason, Thomas Nordahl, Susan Hunter, Sidney S. Chang and Robert Cannon and has published in prestigious journals such as American Journal of Psychiatry, The British Journal of Psychiatry and Journal of Affective Disorders.

In The Last Decade

Charles B. Schaffer

23 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles B. Schaffer United States 13 255 145 81 66 48 24 483
Ljubomir Hotujac Croatia 11 166 0.7× 162 1.1× 63 0.8× 29 0.4× 23 0.5× 31 493
Dean Elbe Canada 10 250 1.0× 105 0.7× 86 1.1× 73 1.1× 29 0.6× 35 414
B.J. Havaki-Kontaxaki Greece 17 426 1.7× 158 1.1× 17 0.2× 113 1.7× 115 2.4× 48 700
Ján Pečeňák Slovakia 15 454 1.8× 207 1.4× 32 0.4× 49 0.7× 48 1.0× 47 683
Ali Doruk Türkiye 13 155 0.6× 158 1.1× 26 0.3× 49 0.7× 44 0.9× 35 430
Myriam Van Moffaert Belgium 15 369 1.4× 220 1.5× 51 0.6× 341 5.2× 148 3.1× 33 815
R Battegay Switzerland 13 151 0.6× 137 0.9× 32 0.4× 90 1.4× 42 0.9× 94 495
G. Eberhard Sweden 10 134 0.5× 89 0.6× 21 0.3× 105 1.6× 81 1.7× 15 468
Beth A. Pangallo United States 15 270 1.1× 188 1.3× 42 0.5× 265 4.0× 123 2.6× 19 641
K Fruensgaard Denmark 11 133 0.5× 145 1.0× 22 0.3× 51 0.8× 34 0.7× 23 316

Countries citing papers authored by Charles B. Schaffer

Since Specialization
Citations

This map shows the geographic impact of Charles B. Schaffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles B. Schaffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles B. Schaffer more than expected).

Fields of papers citing papers by Charles B. Schaffer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles B. Schaffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles B. Schaffer. The network helps show where Charles B. Schaffer may publish in the future.

Co-authorship network of co-authors of Charles B. Schaffer

This figure shows the co-authorship network connecting the top 25 collaborators of Charles B. Schaffer. A scholar is included among the top collaborators of Charles B. Schaffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles B. Schaffer. Charles B. Schaffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schaffer, Charles B., et al.. (2016). An Open Trial of Lurasidone as an Acute and Maintenance Adjunctive Treatment for Outpatients With Treatment-Resistant Bipolar Disorder. Journal of Clinical Psychopharmacology. 36(5). 522–523. 2 indexed citations
2.
Schaffer, Charles B., et al.. (2012). An open trial of pregabalin as an acute and maintenance adjunctive treatment for outpatients with treatment resistant bipolar disorder. Journal of Affective Disorders. 147(1-3). 407–410. 21 indexed citations
3.
Hufton, Jeffrey R., T. C. Golden, R. Quinn, et al.. (2011). Advanced hydrogen and CO2 capture technology for sour syngas. Energy Procedia. 4. 1082–1089. 12 indexed citations
4.
Schaffer, Charles B., et al.. (2010). Efficacy and safety of nonbenzodiazepine hypnotics for chronic insomnia in patients with bipolar disorder. Journal of Affective Disorders. 128(3). 305–308. 11 indexed citations
5.
Schaffer, Charles B., et al.. (2009). Psychiatric reactions to isotretinoin in patients with bipolar disorder. Journal of Affective Disorders. 122(3). 306–308. 40 indexed citations
6.
Schaffer, Charles B., et al.. (2007). Mood-Elevating Effects of Opioid Analgesics in Patients With Bipolar Disorder. Journal of Neuropsychiatry. 19(4). 449–452. 18 indexed citations
7.
Schaffer, Charles B., et al.. (2002). An open case series on the utility of tiagabine as an augmentation in refractory bipolar outpatients. Journal of Affective Disorders. 71(1-3). 259–263. 22 indexed citations
8.
Schaffer, Charles B., et al.. (1999). Open maintenance treatment of bipolar disorder spectrum patients who responded to gabapentin augmentation in the acute phase of treatment. Journal of Affective Disorders. 55(2-3). 237–240. 32 indexed citations
9.
Schaffer, Charles B., et al.. (1999). The use of primidone in the treatment of refractory bipolar disorder.. Annals of Clinical Psychiatry. 11(2). 61–66. 10 indexed citations
10.
Schaffer, Charles B., et al.. (1999). The Use of Primidone in the Treatment of Refractory Bipolar Disorder. Annals of Clinical Psychiatry. 11(2). 61–66. 7 indexed citations
11.
Garvey, Michael J. & Charles B. Schaffer. (1994). Are some symptoms of depression age dependent?. Journal of Affective Disorders. 32(4). 247–251. 28 indexed citations
12.
Garvey, Michael J., Brian L. Cook, G.D. Tollefson, & Charles B. Schaffer. (1989). Antidepressant response in chronic major depression. Comprehensive Psychiatry. 30(3). 214–217. 4 indexed citations
13.
Schaffer, Charles B., Dan Mungas, & Enid Rockwell. (1985). Successful Treatment of Psychotic Depression with. Journal of Clinical Psychopharmacology. 5(4). 233???235–233???235. 7 indexed citations
14.
Abramowitz, Stephen I., et al.. (1984). Borderline personality disorder and the MMPI. Journal of Clinical Psychology. 40(2). 410–413. 14 indexed citations
15.
Cox, Kenneth L., et al.. (1983). Biochemical and ultrasonic abnormalities of the pancreas in anorexia nervosa. Digestive Diseases and Sciences. 28(3). 225–229. 28 indexed citations
16.
Garvey, Michael J., Charles B. Schaffer, & V.B. Tuason. (1983). Relationship of Headaches to Depression. The British Journal of Psychiatry. 143(6). 544–547. 31 indexed citations
17.
Schaffer, Charles B., et al.. (1982). Bioavailability of Intramuscular Versus Oral Haloperidol in Schizophrenic Patients. Journal of Clinical Psychopharmacology. 2(4). 274???276–274???276. 30 indexed citations
18.
Schaffer, Charles B., et al.. (1982). Self-Mutilation and the Borderline Personality. The Journal of Nervous and Mental Disease. 170(8). 468–473. 76 indexed citations
19.
Dysken, Maurice W., et al.. (1981). Fluphenazine pharmacokinetics and therapeutic response. Psychopharmacology. 73(3). 205–210. 59 indexed citations
20.
Schaffer, Charles B., et al.. (1981). Ms. Carroll and Associates Reply. American Journal of Psychiatry. 138(6). 855–b. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ljubomir Hotujac Breakdown of academic impact, for papers by Dean Elbe Breakdown of academic impact, for papers by B.J. Havaki-Kontaxaki Breakdown of academic impact, for papers by Ján Pečeňák Breakdown of academic impact, for papers by Ali Doruk Breakdown of academic impact, for papers by Myriam Van Moffaert Breakdown of academic impact, for papers by R Battegay Breakdown of academic impact, for papers by G. Eberhard Breakdown of academic impact, for papers by Beth A. Pangallo Breakdown of academic impact, for papers by K Fruensgaard
Rankless by CCL
2026